Making a difference for patients at UCLH

We’re funding research fellowships for junior doctors

We will provide funding for junior doctor clinical fellowships which will stimulate more translational and clinical research at UCLH.

We funded Dr Chris Wincup's research about fatique levels in lupus patients. The study has attracted attention from other funding institutions and he will now take the research to PhD level.

Home Case studies We’re funding research fellowships for junior doctors

Translational research

Clinical research is an essential part of UCLH as a research hospital. When Professor Marcel Levi, now Chief Executive and Consultant Physician at UCLH began his post with the Trust in 2017, one of his pledges was to deliver more translational research, and this could be achieved by encouraging junior doctor fellowships which would, in turn, identify and nurture clinical research talent at UCLH and retain candidates longer.

Robert Duke, Associate Director of Medical and Dental Education, is leading on awarding the positions and says that during the fellowship, junior doctors will have dedicated research time, combined with some clinical activity if required. Projects will range between six months and one year and focus on active research areas. Funding for the fellowships are split between UCLH Charity and the research area department.

“The posts are an excellent example of how research can be embedded in patient care and the day to day activities of the Trust”, said Robert. He adds that there has been a lot of interest in the posts which demonstrates a cross-departmental objective to drive innovation and translate advances in research into benefits for patients.

Research profile: Dr Chris Wincup

Area of Interest:

Investigating if a single-dose iron infusion can help improve fatigue levels in lupus patients with functional iron deficiency

What he says:

“I was a medical student nine years ago and have always wanted to research lupus at UCLH. The research fellowship has allowed me to contribute towards a clinical trial that looks to alleviate fatigue, a symptom that 80-90% of Lupus patients consider is the worst symptom.”

“It has been great engaging with patients to see what matters to them and I hope that the results will have significant patient benefit.”